91-100
FINALPhiladelphia
76ers
10-71|L10: 1-9
Charlotte
Hornets
69-96|L10: 5-5
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Charlotte Hornets
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 57-24 | 0.704 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 3/29 | L 85-100 | |
| 3/27 |
| 56-26 |
| 0.683 |
| 1.5 |
| 3 | 47-34 | 0.580 | 10.0 |
| 4 | 47-34 | 0.580 | 10.0 |
| 5 | 47-34 | 0.580 | 10.0 |
| 6 | 45-36 | 0.556 | 12.0 |
| 7 | 43-39 | 0.524 | 14.5 |
| 8 | 42-39 | 0.519 | 15.0 |
| 9 | 40-41 | 0.494 | 17.0 |
| 10 | 35-46 | 0.432 | 22.0 |
| 11 | 66-92 | 0.418 | 29.5 |
| 12 | 33-48 | 0.407 | 24.0 |
| 13 | 32-49 | 0.395 | 25.0 |
| 14 | 10-71 | 0.123 | 47.0 |
| 15 | 0-0 | 0.000 | 16.5 |
| 3/26 | L 105-108 |
| 3/23 | L 103-104 |
| 3/21 | L 75-91 |
| Opponent | Date | Result |
|---|---|---|
| 3/31 | L 87-107 | |
| 3/29 | W 100-85 | |
| 3/29 | L 105-139 | |
| 3/28 | L 99-110 | |
| 3/26 | W 120-110 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 17.7 | 51.6% | 1.9% | 56.4% | |
| 14.5 | 40.3% | 30.1% | 51.4% | |
| 13.0 | 37.5% | 32.6% | 53.8% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 21.0 | 41.5% |
| 35.4% |
| 80.6% |
| 14.6 | 40.4% | 32.3% | 71.1% |
| 13.3 | 58.6% | 25.0% | 70.1% |
| Category | CHA Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #588.6 ORtg | #25107.4 DRtg | CHA |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #110.0% | #1314.4% | PHI |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1035.8% | #1936.0% | CHA |
| Category | CHA Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #9102.7 DRtg | #2781.8 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #2213.2% | #2813.2% | CHA |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1535.4% | #2034.2% | PHI |
